case_images: PMC11329603_01
case_images: Case1: Changes in blood routine-related indices throughout treatment.
case_images: IDR-17-3491-g0001.jpg
case_images: PMC11329603_01_IDR-17-3491-g0001.jpg
case_images: f0001
case_images: RET gradually increased and remained above 100 g/L from May 25, 2023 (Figure 1) (Supplementary Figure 1). Regular chest CT scans were conducted to monitor treatment efficacy (Figure 2), revealing increased absorption of lesions compared to earlier scans.
case_images: Case 1: The dynamic changes in computed tomography scans of the patient following corresponding treatment. Starting from July 6, 2023, the lesions began to stabilize.
case_images: IDR-17-3491-g0002.jpg
case_images: PMC11329603_01_IDR-17-3491-g0002.jpg
case_images: f0002
case_images: RET gradually increased and remained above 100 g/L from May 25, 2023 (Figure 1) (Supplementary Figure 1). Regular chest CT scans were conducted to monitor treatment efficacy (Figure 2), revealing increased absorption of lesions compared to earlier scans.
case_images: PMC11329603_02
case_images: Case 2: Changes in blood routine-related indices throughout the treatment.
case_images: IDR-17-3491-g0003.jpg
case_images: PMC11329603_02_IDR-17-3491-g0003.jpg
case_images: f0003
case_images: Regular blood testing showed a gradual increase in HGB levels from 82g/L on December 29, 2022, to over 100g/L on January 29, 2024, with the highest level recorded as 111g/L on November 27, 2023 (Figure 3).
case_images: PMC11329603_03
case_images: Case 3: Changes in blood routine-related indices throughout treatment.
case_images: IDR-17-3491-g0004.jpg
case_images: PMC11329603_03_IDR-17-3491-g0004.jpg
case_images: f0004
case_images: By November 1, 2023, the HGB had risen to 102 g/L (Figure 4).
case_images: PMC11329603_04
case_images: Case 4: DR-TB treatment regimen used in patient and correlated with side effects and interventions.
case_images: IDR-17-3491-g0005.jpg
case_images: PMC11329603_04_IDR-17-3491-g0005.jpg
case_images: f0005
case_images: The patient was considered cured on February 23, 2023 (Figure 5).
case_images: PMC11329603_05
case_images: Case 5: Changes in blood routine-related indices throughout treatment.
case_images: IDR-17-3491-g0006.jpg
case_images: PMC11329603_05_IDR-17-3491-g0006.jpg
case_images: f0006
case_images: Remarkably, the patient's WBC and neutrophil counts showed no further decline throughout nearly two years of treatment, remaining stable at 2-3*10^9/L for WBC and above 1.0*10^9/L for neutrophils, with HGB consistently maintained above 80g/L, and at the time of discontinuation, HGB level was recorded at 117g/L (Figure 6).